2025
SJR Q1
JCR Q1 · 81,2
OA
1 matched articles
SCIE
Journal detail
Signal Transduction and Targeted Therapy
- Publisher
- Springer Nature
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
2059363520959907
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 17,74
- Quartile Q1
- H-Index 224
- Cites/doc 51,26
- Docs (3y) 1.207
- Cites (3y) 58.350
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 81,2
- 5Y JIF 74,6
- JCI 6,13
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q1
- Genetics Q1
Areas
- Biochemistry, Genetics and Molecular Biology
WoS categories
- Biochemistry & Molecular Biology | Cell Biology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 17,74 | 81,2 | 74,6 | 6,13 | Q1 | 224 |
| 2024 | Q1 | Q1 | 12,135 | 52,7 | 52,2 | 5,03 | Q1 | 161 |
| 2023 | Q1 | Q1 | 8,737 | 40,8 | 40,6 | 4,42 | Q1 | 161 |
| 2022 | Q1 | Q1 | 6,63 | 39,3 | 37,2 | 3,7 | Q1 | 161 |
| 2021 | Q1 | Q1 | 5,157 | 38,1 | 35,1 | 2,96 | Q1 | 161 |
| 2020 | Q1 | Q1 | 4,284 | 18,2 | 21,2 | 1,85 | Q1 | 161 |
| 2019 | Q1 | Q1 | 3,755 | 13,5 | 13,2 | 1,57 | Q1 | 161 |
| 2018 | — | Q1 | — | 5,9 | 5,9 | 1,03 | Q2 | — |
| 2017 | — | — | — | — | — | — | — | 161 |
| 2016 | — | — | — | — | — | — | — | 161 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 1/328 |
| 2025 | CELL BIOLOGY | SCIE | Q1 | Q1 | 2/207 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 1/320 |
| 2024 | CELL BIOLOGY | SCIE | Q1 | Q1 | 2/204 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 3/313 |
| 2023 | CELL BIOLOGY | SCIE | Q1 | Q1 | 5/205 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 3/285 |
| 2022 | CELL BIOLOGY | SCIE | Q1 | Q1 | 6/191 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 4/297 |
| 2021 | CELL BIOLOGY | SCIE | Q1 | Q1 | 6/195 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 5/295 |
| 2020 | CELL BIOLOGY | SCIE | Q1 | Q1 | 11/195 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 9/297 |
| 2019 | CELL BIOLOGY | SCIE | Q1 | Q1 | 14/195 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q2 | 39/299 |
| 2018 | CELL BIOLOGY | SCIE | Q1 | Q2 | 39/193 |